AVITA Medical, Inc. - Depositary Receipt (Common Stock) - Laporan Laba Rugi (TTM)

AVITA Medical, Inc. - Depositary Receipt (Common Stock)
AU ˙ ASX ˙ AU000000AVH4
A$ 1.34 ↑0.01 (0.75%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi AVITA Medical, Inc. - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 16 18 23 29 31 33 32 30 32 34 37 41 45 50 51 54 60 64 72 75
Change (%) 11.47 27.28 28.18 6.70 5.88 -3.71 -6.19 6.95 7.90 8.75 9.13 11.15 10.44 1.10 6.79 10.90 7.01 11.53 4.50
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 3 3 5 6 6 6 6 5 6 6 6 7 7 8 8 8 9 9 10 12
Change (%) -0.76 46.41 24.72 2.67 -0.07 -6.03 -11.63 8.72 9.62 -1.84 13.79 8.64 6.12 -1.98 -1.22 14.30 5.62 14.52 13.05
% of Revenue 20.43 18.18 20.92 20.35 19.58 18.48 18.04 16.99 17.27 17.55 15.84 16.52 16.15 15.52 15.04 13.91 14.34 14.15 14.53 15.72
Gross Operating Profit 13 15 18 23 25 27 26 25 26 28 32 34 38 42 43 47 51 55 61 63
Change (%) 14.61 23.03 29.10 7.74 7.32 -3.19 -5.00 6.58 7.54 11.00 8.25 11.64 11.27 1.67 8.21 10.35 7.25 11.04 3.04
% of Revenue 79.57 81.82 79.08 79.65 80.42 81.52 81.96 83.01 82.73 82.45 84.16 83.48 83.85 84.48 84.96 86.09 85.66 85.85 85.47 84.28
SG&A 54 50 42 37 34 38 41 43 44 45 48 53 59 66 72 80 88 91 91 88
Change (%) -5.95 -16.05 -12.41 -7.29 10.36 8.68 3.35 3.63 2.50 5.47 11.23 11.77 10.63 10.31 10.58 10.08 3.71 -0.41 -3.12
% of Revenue 333.43 281.31 185.53 126.78 110.16 114.82 129.59 142.78 138.36 131.44 127.47 129.92 130.66 130.88 142.80 147.86 146.77 142.24 127.00 117.74
R&D 11 11 13 15 15 16 15 14 15 14 15 17 17 21 21 21 22 20 21 22
Change (%) 1.49 14.59 16.87 0.09 5.64 -3.12 -6.03 2.88 -5.58 6.97 13.61 3.53 19.42 2.92 -0.88 4.87 -8.59 5.35 1.07
% of Revenue 67.83 61.76 55.60 50.69 47.55 47.45 47.74 47.82 46.00 40.26 39.60 41.22 38.40 41.52 42.27 39.23 37.10 31.69 29.93 28.95
OpEx 65 62 58 56 53 58 60 60 62 62 65 74 82 93 101 109 119 121 123 122
Change (%) -4.77 -7.28 -3.28 -4.13 8.67 3.91 -0.52 3.12 -0.01 5.55 12.57 11.03 13.59 8.46 7.86 9.57 1.59 1.68 -1.02
% of Revenue 406.32 347.11 252.86 190.79 171.41 175.93 189.85 201.34 194.13 179.91 174.61 180.11 179.93 185.07 198.53 200.51 198.11 188.08 171.47 162.42
Operating Income -49 -44 -35 -27 -22 -25 -29 -30 -30 -28 -28 -33 -36 -43 -50 -54 -59 -57 -51 -47
Change (%) -10.08 -21.27 -23.86 -16.07 12.57 13.94 5.80 -0.66 -8.41 1.54 17.17 10.89 17.54 17.10 8.94 8.26 -3.93 -9.50 -8.74
% of Revenue -306.32 -247.11 -152.86 -90.79 -71.41 -75.93 -89.85 -101.34 -94.13 -79.91 -74.61 -80.11 -79.93 -85.07 -98.53 -100.51 -98.11 -88.08 -71.47 -62.42
Interest Expense -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -776 -777 -779 -780 -211 -211 -212
Change (%) -20.69 -8.70 4.76 9.09 20.83 -10.34 -19.23 -14.29 -11.11 25.00 15.00 17.39 2,874,503.70 0.17 0.17 0.17 -72.91 -0.06 0.33
% of Revenue -0.18 -0.13 -0.09 -0.08 -0.08 -0.09 -0.08 -0.07 -0.06 -0.05 -0.05 -0.06 -0.06 -1,547.86 -1,533.61 -1,438.58 -1,299.44 -328.96 -294.77 -283.03
Net Income -49 -44 -35 -27 -22 -25 -29 -30 -30 -27 -26 -31 -34 -35 -45 -50 -57 -62 -57 -52
Change (%) -9.98 -20.65 -23.57 -16.10 12.72 13.79 5.39 -1.19 -10.49 -0.91 15.60 10.23 5.08 26.68 11.18 15.04 7.89 -7.76 -9.59
% of Revenue -302.94 -244.63 -152.51 -90.94 -71.51 -76.13 -89.97 -101.08 -93.38 -77.47 -70.59 -74.77 -74.16 -70.56 -88.41 -92.04 -95.47 -96.26 -79.61 -68.87

Source: Capital IQ

Other Listings
US:AVHHL
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista